Immune Regen Bio Sciences INC

Since 2003, Immuneregen Biosciences, Inc has been providing Pharmaceutical Preparations from Scottsdale. Immuneregen Biosciences, Inc has estimated annual revenues of $520,000.00 and also employs an estimated 5 employees.

ImmuneRegen BioSciences Inc. is a wholly owned subsidiary of IR BioSciences Holdings Inc., which is a development-stage biotechnology company. It is engaged in the research and development of the potential drug candidate, Homspera, as well as its derivatives. The biotechnology company develops drug candidates for regenerating or strengthening the human immune system through stimulation of human...